Dr. Mary Scollay

Racing Medication and Testing Consortium to Fund Postdoctoral Fellowship

The Racing Medication & Testing Consortium (RMTC) has announced that it will fund the research proposal, "Detection of Bisphosphonates Using Metabolomics," submitted by Dr. Bethany Keen at the University of Pennsylvania's Equine Testing and Research Laboratory. Dr. Keen's research to date has been conducted in Australia and focused on equine anti-doping, analytical chemistry, and statistics. Metabolomics is an emerging field in doping control and represents a novel testing approach that identifies cellular effects unique to a class of drugs rather than identifying the specific molecule responsible for those effects. "The...

[ Read More ]
RMTC Announces Post-Doctorate Fellowship Program

Edited Press Release Racing Medication and Testing Consortium (RMTC) has announced their support of post-doctoral training by funding a Fellowship Program beginning in 2022. The need for establishing such a program is two-fold:   To promote a sustained research program with a core focus on anti-doping, to include topics related to drug testing, development of new analytical methods with application to racing chemistry, pharmacokinetics/pharmacodynamics, forensic toxicology, or other related disciplines. The future of horseracing's anti-doping programs requires mentoring young scientists to become researchers, racing laboratory directors, and industry leaders. Innovation...

[ Read More ]

Never miss another story from the TDN

Click Here to sign up for a free subscription.